4//SEC Filing
IOMED INC 4
Accession 0001232787-07-000006
CIK 0001041652operating
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 2:17 PM ET
Size
25.0 KB
Accession
0001232787-07-000006
Insider Transaction Report
Form 4
IOMED INCIOX
WARDLE PETER J
Director
Transactions
- Disposition to Issuer
stock option
2007-08-09$2.55/sh−15,000$38,250→ 0 totalExercise: $2.55From: 2007-08-09Exp: 2007-08-09→ common stock (15,000 underlying) - Disposition to Issuer
Common Stock
2007-08-09$2.75/sh−185,570$510,318→ 0 total - Disposition to Issuer
stock options
2007-08-09$1.72/sh−15,000$25,800→ 0 totalExercise: $1.72From: 2007-08-09Exp: 2007-08-09→ common stock (15,000 underlying) - Disposition to Issuer
stock options
2007-08-09$3.88/sh−10,000$38,750→ 0 totalExercise: $3.88From: 2007-08-09Exp: 2007-08-09→ common stock (10,000 underlying) - Disposition to Issuer
stock option
2007-08-09$2.25/sh−10,000$22,500→ 0 totalExercise: $2.25From: 2007-08-09Exp: 2007-08-09→ common stock (10,000 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to merger agreement between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. in exchange for a cash paymetn of $2.75 per share on the effective date of the merger.
- [F2]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. A cash payment representing the difference between the exercise price of the option and the market value of the underlying Iomed common stock on the effective date of the merger ($2.75 per share) was made.
- [F3]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. There was no cash payment made because the option price was below the market value of the underlying Iomed common stock on the effective date of the merger.
Documents
Issuer
IOMED INC
CIK 0001041652
Entity typeoperating
IncorporatedUT
Related Parties
1- filerCIK 0001041652
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 2:17 PM ET
- Size
- 25.0 KB